A Phase 1a/1b Study of LY3537982 in Patients with KRAS G12C-Mutant Advanced Solid Tumors
Are you eligible to participate in this study?
You may be eligible for this study if you meet the following criteria:
Conditions: cancer | KRAS G12C-Mutant Advanced Solid Tumors
Age: Between 18 - 100 Years
Gender: Male or Female
Recruitment StatusEnrolling By Invitation
If you need help finding a study or have any questions, please contact us at email@example.com or by phone at (888) 264-0005.